Loading clinical trials...

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm

NCT00092131•Organon and Co

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in participants who have a history of worsening asthma after exercise.

Eligibility

Age

15 - 45 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Participants with mild-to-moderate asthma

Exclusion Criteria

•Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection

Key Dates

Start Date

June 1, 2003

Primary Completion Date

November 1, 2003

Completion Date

November 1, 2003

Last Updated

February 2, 2022

Enrollment

ACTUAL participants

Conditions

Asthma, Exercise-Induced

Interventions

Comparator: Montelukast

DRUG

Comparator: Placebo

DRUG

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

NCT00245570

Asthma, Exercise-Induced

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions